Genovis announces a strategic partnership with Dutch CRO Single Cell Discoveries. While the market reaction has been muted, the deal further strengthens the Genomics growth trajectory, where the SEQURNA RNase inhibitor sales already doubled in 2025, supporting a continued strong growth outlook in 2026.
LÄS MER